Together, these data suggest that mTORC2 signaling can be a driver of protein acetylation and redistribute EZH2 in the DNMT3A promoter to suppress its mRNA/protein expression in GBM (Fig. 3H). The gene discussed is DNMT3A; the disease is glioblastoma.